Darier Disease with Acrokeratosis Verruciformis of Hopf and their Aggravation on Lithium Therapy for Bipolar Disorder

被引:0
|
作者
Sharma, Avinash [1 ]
Saini, Brij Kishore [2 ]
Jain, Suresh Kumar [1 ,3 ]
Kushwaha, Ramesh Kumar [1 ]
机构
[1] Govt Med Coll, Dept Dermatol Venereol & Leprol, Kota, Rajasthan, India
[2] Govt Med Coll, Dept Psychiat, Kota, Rajasthan, India
[3] Govt Med Coll, Kota 324005, Rajasthan, India
关键词
Acrokeratosis verruciformis of Hopf; bipolar disorder; Darier disease; lithium;
D O I
10.4103/ijpd.ijpd_60_22
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Darier disease (DD) and acrokeratosis verruciformis of Hopf are rare autosomal dominant skin disorders. Both are caused by a single gene mutation, i.e., ATP2A2 located on chromosome 12, which is expressed in the skin and brain. However, both the diseases are clinically and histopathologically distinct. DD is associated with many neuropsychiatric conditions such as depression, bipolar disorder (BPD), and seizures. Lithium is commonly used as a mood stabilizer in psychiatry and is reported to aggravate DD. We report a case of a 17-year-old female with DD and acrokeratosis verruciformis with associated with BPD Type 1 presenting with an aggravation of skin lesions after starting lithium therapy.
引用
收藏
页码:238 / 240
页数:3
相关论文
共 45 条
  • [1] Brief Report: HPV-17 Infection in Darier Disease With Acrokeratosis Verrucosis of Hopf
    Matsumoto, Andrew
    Gregory, Neal
    Rady, Peter L.
    Tyring, Stephen K.
    Carlson, John A.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2017, 39 (05) : 370 - 373
  • [2] Lithium Therapy for Bipolar Disorder
    Luu, Brent
    Rodway, George
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (02): : 93 - 99
  • [3] Recurrent ATP2A2 p.(Pro602Leu) mutation differentiates Acrokeratosis verruciformis of Hopf from the allelic condition Darier disease
    Ronan, Anne
    Ingrey, Angela
    Murray, Natalia
    Chee, Paul
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (07) : 1975 - 1978
  • [4] Lithium in maintenance therapy for bipolar disorder
    Young, AH
    Newham, JI
    JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (02) : 17 - 22
  • [5] Antioxidant status of the patients with bipolar disorder on lithium therapy
    Dubey, Raju Kumar
    Lamsal, Madhab
    Baral, Nirmal
    Shyangwa, Pramod Mohan
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S52 - S53
  • [6] The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder
    Zhou, Yuyang
    Zheng, Weizhi
    Guo, Feichang
    Wu, Shijin
    Zhong, Congjie
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025,
  • [7] Serum lithium levels and the outcome of maintenance therapy of bipolar disorder
    Hopkins, HS
    Gelenberg, AJ
    BIPOLAR DISORDERS, 2000, 2 (03) : 174 - 179
  • [8] Exacerbation of Darier's disease with oral lithium carbonate therapy
    Jones, SAV
    Grabczynska, SA
    Mufti, KL
    VijayasinghamHenderson, S
    Eady, RAJ
    EUROPEAN JOURNAL OF DERMATOLOGY, 1996, 6 (07) : 527 - 528
  • [9] Lithium continuation for a patient with bipolar disorder and chronic kidney disease
    Singh, Balwinder
    Nunez, Nicolas A.
    Schock, Lisa
    Joseph, Boney
    Kohoutek, Bradley
    Roerig, James L.
    BIPOLAR DISORDERS, 2020, 22 (03) : 316 - 318
  • [10] The association between Darier disease, bipolar disorder, and schizophrenia revisited: a population-based family study
    Cederlof, Martin
    Bergen, Sarah E.
    Langstrom, Niklas
    Larsson, Henrik
    Boman, Marcus
    Craddock, Nick
    Ostberg, Per
    Lundstrom, Sebastian
    Sjolander, Arvid
    Nordlind, Klas
    Landen, Mikael
    Lichtenstein, Paul
    BIPOLAR DISORDERS, 2015, 17 (03) : 340 - 344